Related Experiment Video
Updated: Apr 25, 2026

04:39
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
2.8K
Association between idiopathic retroperitoneal fibrosis and autoimmune thyroiditis: a case-control study
Graziano Ceresini1, Maria L Urban2, Domenico Corradi3
1Department of Clinical and Experimental Medicine, Endocrinology of Aging Unit, University of Parma, Parma, Italy.
Autoimmunity Reviews
|August 31, 2014
Summary
Patients with idiopathic retroperitoneal fibrosis (IRF) have a significantly higher risk of developing Hashimoto's thyroiditis (HT). Regular thyroid function monitoring is recommended for individuals diagnosed with IRF.
Area of Science:
- Endocrinology
- Autoimmune Diseases
- Rare Diseases
Background:
- Idiopathic retroperitoneal fibrosis (IRF) is a rare condition often linked to autoimmune disorders.
- The association between IRF and Hashimoto's thyroiditis (HT) remains poorly understood, with limited evidence from case reports.
- This study aimed to determine the prevalence of HT in a large cohort of IRF patients compared to matched controls.
Purpose of the Study:
- To investigate the prevalence of Hashimoto's thyroiditis (HT) in patients with idiopathic retroperitoneal fibrosis (IRF).
- To assess the association between IRF and autoimmune thyroiditis using serological and imaging markers.
- To evaluate the long-term thyroid function in IRF patients.
Main Methods:
- Cross-sectional study of 73 new-onset IRF patients and 71 controls.
- Evaluation of anti-thyroperoxidase antibodies (AbTPO), free thyroxine (FT4), and thyroid-stimulating hormone (TSH).
- Thyroid ultrasound (US), fine-needle aspiration biopsy (FNAB), and thyroidectomy histology were used for diagnosis.
Main Results:
- IRF patients showed a higher prevalence of AbTPO positivity and US findings suggestive of autoimmune thyroiditis (US-AIT) compared to controls.
- Logistic regression revealed a significantly higher risk of AbTPO-diagnosed HT (OR=3.56) and US-AIT (OR=4.74) in IRF patients.
- At follow-up, 25% of IRF patients required l-thyroxine treatment, versus 3% of controls.
Conclusions:
- Idiopathic retroperitoneal fibrosis (IRF) is associated with an increased risk of Hashimoto's thyroiditis (HT).
- Routine thyroid function monitoring is crucial for patients diagnosed with IRF.
- Autoimmune thyroiditis may be a significant comorbidity in IRF patients.

